Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Enrolling by invitation · NCT07637162 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia | Hyperalgesia, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorder | Enrolling by invitation | Phase 3 | 2026-09-04 | NCT07637162 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Axsome Therapeutics, Inc. | 14 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||